Medix Biochemica acquires U.S. diagnostic base matrix supplier

By LabPulse.com staff writers

June 20, 2022 -- Espoo, Finland-based Medix Biochemica announced Monday that it has acquired Florida-based Bioresource Technology (BRT) to broaden its diagnostic base matrix capabilities and strengthen its presence in the U.S. IVD market.

Medix said that the acquisition will enable it to provide customers with a comprehensive offering of raw materials for their IVD quality control products.

The organization and operations of BRT will form a significant part of Medix Biochemica's IVD Biomaterials Business Unit, which also comprises the manufacturing of native antigens, enzymes, proteins, and biologicals in St. Louis, Missouri.

BRT's operations will stay in Weston, Florida, and BRT's president Derik Reichenbach and CEO Ron Dilling will remain as strategic advisors following the acquisition.

GBS to acquire drug screening firm Intelligent Fingerprinting
GBS has inked a deal to acquire Intelligent Fingerprinting, a developer of point-of-care diagnostic screening technology for opioids and drugs of abuse.
StatLab acquires histology and cytology manufacturer CellPath
Medical diagnostic supplies manufacturer StatLab Medical Products has acquired the U.K.-based histology and cytology product manufacturer CellPath.
Medix Biochemica acquires MyPols Biotec
Medix Biochemica has purchased German biotechnology company MyPols Biotec in a deal aimed at expanding its portfolio of molecular diagnostics raw materials...

Copyright © 2022 LabPulse.com

Last Updated mp 6/20/2022 11:20:51 AM